NDC Compounded Drug 72934-1545-2 Niacinamide; Tretinoin
Gel Topical
Compounded Drug Product Information
NDC Crossover Products Matching Niacinamide; Tretinoin
NDC crossover of Sirvana with NDC 72934-1545 a human compounded drug with other similar products matching the same substance name (Niacinamide; Tretinoin) and the same administration route (topical) or dosage form (gel).
| NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
|---|---|---|---|---|---|---|
| 72934-1304-2 | Varoxia Gel | 011020 Niacinamide 4% / Tretinoin 0.05% | 30 mL in 1 BOTTLE, PUMP | Gel | Topical | Sknv |
| 72934-1304-2 | Varoxia Gel | 011020 Niacinamide 4% / Tretinoin 0.05% | 30 mL in 1 BOTTLE, PUMP | Gel | Topical | Sknv |
| 72934-1304-2 | Varoxia Gel | 011020 Niacinamide 4% / Tretinoin 0.05% | 30 mL in 1 BOTTLE, PUMP | Gel | Topical | Sknv |
| 72934-1413-2 | Idyyxiatar Gel | 271006 Niacinamide 5% / Tretinoin 0.025% | 30 mL in 1 BOTTLE, PUMP | Gel | Topical | Sknv |
| 72934-1564-2 | Aluris | 011020 Niacinamide 4% / Tretinoin 0.05% | 30 g in 1 BOTTLE, PUMP | Gel | Topical | Sknv |
Frequently Asked Questions
What is the NDC number assigned to Aluris?
Aluris was assigned by its manufacturer with NDC product code 72934-1545. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Aluris?
The NDC package code 72934-1545-2 was assigned to a 30 g in 1 BOTTLE, PUMP of niacinamide; tretinoin administered topical via gel.
Who manufactures this product?
Aluris is manufactured by an outsourced facility and labeled by Sknv. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 5 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by SKNV with NDC product codes 72934-1304-2, 72934-1304-2, 72934-1304-2, 72934-1413-2 and 72934-1564-2.